Investment
Features
FeesSafety
Academy
More
Pluang+

Quantum computing poses future risks to blockchain security; Bitcoin and Ethereum plan defenses.

Market News
23 Sep 2026
Blockonomi
View Source
Neutral
Quantum computing poses future risks to blockchain security; Bitcoin and Ethereum plan defenses.

European financial regulators warn that advancing quantum computing could threaten blockchain cryptography protecting Bitcoin, Ethereum, and other systems. Though no current quantum computer can break these encryptions, Google's new research lowers the estimated quantum power needed to do so, raising urgency. Bitcoin developers propose phased upgrades to eliminate vulnerable signature schemes, while Ethereum aims for full quantum resistance by December 2029. These efforts focus on proactive preparation to secure cryptocurrency networks before powerful quantum machines emerge.

Quantum computing's emerging threat to Bitcoin security is the focus here, with Pluang's market snapshot as of Sep 23, 2026 21:02 WIB showing that out of 50 major cryptocurrencies, 27 rose and 22 fell. Notable movers include LINK at Rp226.156 with a 1-day change of -3.92% and a typical hold time of 63 days, CRV at Rp6.275 down 3.92% with a 61-day hold, and AXS at Rp20.175 up 3.90% with a 62-day hold and a Pluang order activity heavily skewed to selling at 97%.

More News

New crypto Pepeto raises $11.23M amid Ethereum's bullish $10,000 price forecast for 2026.

New crypto Pepeto raises $11.23M amid Ethereum's bullish $10,000 price forecast for 2026.

Pepeto, a new cryptocurrency on the Ethereum network, has quickly raised over $11.23 million in its presale, with each funding stage closing faster than the last. This momentum comes as Ethereum is predicted to reach $10,000 by the end of 2026, drive...

Market News
Bullish
1 hour ago
BlackRock's stake in Fagron drops below 3% after share transfers, holding 2.96% voting rights as of October 2026.

BlackRock's stake in Fagron drops below 3% after share transfers, holding 2.96% voting rights as of October 2026.

BlackRock, Inc. disclosed that its voting rights in pharmaceutical company Fagron NV fell below the 3% reporting threshold due to the transfer of voting securities, despite acquiring financial instruments equivalent to voting rights. As of October 12...

Market News
Neutral
2 hours ago
FDA approves phentolamine eye drops for presbyopia, offering a new treatment for age-related near vision loss.

FDA approves phentolamine eye drops for presbyopia, offering a new treatment for age-related near vision loss.

Opus Genetics announced FDA approval of phentolamine ophthalmic solution 0.75% for treating presbyopia, an age-related condition affecting near vision in adults. This approval, based on successful Phase 3 trials, provides a non-invasive option that i...

Market News
Bullish
2 hours ago
K2 Vision performs 5,000 Light Adjustable Lens procedures, leading globally in this advanced vision tech.

K2 Vision performs 5,000 Light Adjustable Lens procedures, leading globally in this advanced vision tech.

K2 Vision has completed over 5,000 procedures using the Light Adjustable Lens (LAL), making it the highest-volume practice worldwide for this technology. The LAL is unique because it can be adjusted after implantation to fine-tune vision based on the...

Market News
Bullish
2 hours ago
BlackRock's stake in Fagron falls below 3% after share disposals, now holding 2.96% voting rights.

BlackRock's stake in Fagron falls below 3% after share disposals, now holding 2.96% voting rights.

BlackRock, Inc. disclosed that its shareholding in Fagron NV dropped below the 3% threshold to 2.96% after selling some voting securities, despite acquiring equivalent financial instruments. As of October 12, 2026, BlackRock holds 2,015,779 voting ri...

Market News
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App